Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Moleculin Biotech, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 25 | 23 | −2 |
| Shares | 2.99M | 3.03M | +34.1K (+1.1%) |
| Value | $3.17M | $2.91M | −$265.6K (−8.4%) |
New holders (4)
Institutions that held Moleculin Biotech, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 23,940 | $23.0K | 0.00% |
| HRT Financial LP | 15,635 | $15.0K | 0.00% |
| Two Sigma Securities, LLC | 13,521 | $13.0K | 0.00% |
| Susquehanna International Group, LLP | 11,101 | $10.7K | 0.00% |
Sold out (6)
Institutions that held Moleculin Biotech, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Charles Schwab Investment Management Inc | 36,606 | $38.8K |
| UBS Group AG | 11,243 | $11.9K |
| Rockefeller Capital Management L.P. | 1,792 | $1.00K |
| Clearstead Advisors, LLC | 600 | $636 |
| Global Retirement Partners, LLC | 168 | $178 |
| Massmutual Trust Co FSB | 167 | $0 |